InsidersTradesSigma
Follow the 海尔生物 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 海尔生物 has published 1 insider filings. Market capitalisation: €8.8bn. The latest transaction was reported on 31 October 2024 (Purchase). Among the most active insiders: 江兰. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Haier Biomedical is a company specializing in the healthcare and pharmaceutical sector, providing innovative solutions for the storage and management of biological samples. It is listed on the Shanghai Stock Exchange.